首页> 外文期刊>Journal of Zhejiang University >A new mutation (1062 del 16) of iduronate-2-sulfatase gene from a Chinese patient with Hunter syndrome
【24h】

A new mutation (1062 del 16) of iduronate-2-sulfatase gene from a Chinese patient with Hunter syndrome

机译:中国亨特氏综合征患者的一个新的突变(1062 del 16)的idurnate-2-sulfatase基因

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To identify the mutations of iduronate-2-sulfatase (IDS) gene, to reveal its mutation features, and to establish a basis for genetic counseling and prenatal gene diagnosis of Hunter syndrome. Methods: Urine glycosaminoglycans (GAGs) assay, PCR and DNA sequencing were performed to detect mutation of IDS gene of the patient and his parents. Results: The result showed that the patient was: DS(++), HS(++), KS(-), CS(-), and that both of his parents were negative. A frame-shift deletion mutation (1062 del 16) was identified in exon 7 of the patient's IDS gene. His parents' genotypes were normal. Conclusion: The patient's mutation was not inherited by his parents but a novel one. The mutation probably altered the primary structure and tertiary structure of IDS enzyme protein remarkably and lowered the activity of IDS enzyme greatly. Therefore it is supposed to be the direct cause of the disorder.
机译:目的:鉴定异氰酸酯-2-硫酸酯酶(IDS)基因的突变,揭示其突变特征,为亨特综合征的遗传咨询和产前基因诊断奠定基础。方法:采用尿糖胺聚糖(GAGs)检测,PCR和DNA测序技术检测患者及其父母的IDS基因突变。结果:结果表明该患者为:DS(++),HS(++),KS(-),CS(-),并且他的父母均为阴性。在患者IDS基因第7外显子中鉴定出移码缺失突变(1062 del 16)。他父母的基因型正常。结论:患者的突变不是父母遗传的,而是一种新颖的突变。该突变可能显着改变了IDS酶蛋白的一级结构和三级结构,并大大降低了IDS酶的活性。因此,这被认为是疾病的直接原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号